⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 28, 2024Clinical Transplantation

Racial–ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy

Rafal D. Mazur David C. Cron David Goldberg Heidi Yeh Leigh Anne Dageforde

View Full Paper

Ask AI

Bookmark

Share

Abstract

In May 2019, liver transplant (LT) allocation policy changed to limit MELD exception points for hepatocellular carcinoma (HCC) to median MELD at transplant minus three (MMaT-3). We evaluated this policy's impact on waitlist outcomes for HCC candidates, by race and ethnicity, hypothesizing that the introduction of the MMaT-3 reduced inequities in waitlist outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mazur et al. (2024) studied this question.

synapsesocial.com/papers/68e68100b6db64358760a231 https://doi.org/10.1111/ctr.15365

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Redefining liver transplant priority: Waitlist outcomes for HCC after MMaT-3 donor hospital-based allocation reform.Original Research · 2026
2Time to transplant by sociodemographic group following MELD 3.0 implementation in hepatocellular carcinoma.Original Research · 2026
3Impact of the geographic redistribution of MMaT-3 policy on regional and socioeconomic disparities in hepatocellular carcinoma transplantation.Retrospective Study · 2026
4Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy2024 · 12 citations
5Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy2025